Target intelligence / Profile preview

U6 small nuclear RNA 362, pseudogene (RNU6-362P)

Target
RNU6-362P
Molecular classification
Non-coding RNA (pseudogene), Small nuclear RNA (snRNA) pseudogene, Other
01

Overview

RNU6-362P is a **processed pseudogene** of the gene encoding U6 small nuclear RNA, a non-coding RNA component essential for mRNA splicing as part of the major spliceosome[3][1]. While functional U6 snRNA participates directly in the splicing process by associating with other snRNAs and proteins to form catalytic complexes[3][1], RNU6-362P itself is a non-functional pseudogene copy and does not produce a functional RNA molecule. Pseudogenes like RNU6-362P generally do not encode active gene products and are not considered therapeutic targets, though the broader class of snRNA pseudogenes can occasionally acquire regulatory roles or affect genomic stability[2]. There are no known drugs, therapeutic indications, or safety issues related to this specific pseudogene. **Additional context:** - Functional U6 snRNA is deeply conserved and essential for eukaryotic viability, but extinct or non-transcribed pseudogenes such as RNU6-362P are simply remnants in the genome with no direct role in cell biology or disease[3][1]. - Pseudogenes, by definition, are not considered targets for therapeutic intervention, diagnosis, or biomarker use[2].

Other names
RNA, U6 small nuclear 362, pseudogeneRNU6-362P
02

Biological functions

None (no known biological function, as pseudogenes are generally nonfunctional copies of parent genes)
03

Disease associations

Other (no specific disease role for this pseudogene; in general, some pseudogenes can have regulatory roles or be implicated in disease through rare mechanisms, but no evidence for this specific locus)

Beyond the preview

Go deeper on U6 small nuclear RNA 362, pseudogene (RNU6-362P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on U6 small nuclear RNA 362, pseudogene (RNU6-362P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call